pre-IPO PHARMA

COMPANY OVERVIEW

Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutic development company. Forge's mission is to enable access to life changing gene therapies and help bring them from idea into reality. Forge has a 175,000 ft2 facility in Columbus, Ohio, "The Hearth", to serve as their headquarters. The Hearth is the home of a custom-designed cGMP facility dedicated to AAV viral vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most.


LOCATION


THERAPEUTIC AREAS


WEBSITE

https://www.forgebiologics.com/


CAREER WEBSITE

https://www.forgebiologics.com/careers/


SOCIAL MEDIA


INVESTORS


PRESS RELEASES


Sep 5, 2023

Forge Biologics to Participate in Multiple September Investor Conferences


Jun 28, 2023

New Hope Research Foundation and Forge Biologics Announce cGMP Manufacturing Partnership to Accelerate Gene Therapy for Patients with Tay-Sachs Disease


May 23, 2023

Forge Biologics Joins Bespoke Gene Therapy Consortium (BGTC) as Partner to Accelerate the Development and Manufacturing of AAV Gene Therapies for Patients with Rare Diseases


May 11, 2023

Forge Biologics Announces Eight Presentations at the Upcoming 2023 Meeting of the American Society of Gene and Cell Therapy (ASGCT)


May 8, 2023

Life Biosciences and Forge Biologics Announce cGMP Manufacturing Partnership to Advance Development of Novel Gene Therapies for Aging-Related Diseases


For More Press Releases


Google Analytics Alternative